Bibliography.doc.doc

820 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
820
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Bibliography.doc.doc

  1. 1. September 2010 BIBLIOGRAPHY CONTENTS PEER REVIEW PUBLICATIONS:...................................................................1 ORIGINAL ARTICLES (Peer Reviewed Journals):..........................1 ABSTRACTS (Journal):...................................................................3 ABSTRACTS (Proceedings of Meetings):.......................................4 NON PEER REVIEW PUBLICATIONS:..........................................8 BOOK CHAPTERS: 8 2011 Goodyear M, Weitzer R. International trends in the control of sexual services, in Dewey S, Kelly P (eds.), Desire and Labor in Economic Crisis, New York University Press (in press)...................................9 ORIGINAL ARTICLES: 9 EDITORIALS: 9 LETTERS: 10 ELECTRONIC LETTERS:.............................................................11 MONOGRAPHS, DISCUSSION AND POLICY PAPERS:.............13 PUBLICATIONS ON GENERAL TOPICS:.....................................14 BOOK REVIEWS: 14 COMMITTEE PRESENTATIONS:.................................................14 THESES: 14 SOFTWARE:.................................................................................................14 PEER REVIEW PUBLICATIONS: ORIGINAL ARTICLES (Peer Reviewed Journals): 1971 Johns MW, Gay TJ, Goodyear MD, Masterton JP: Sleep habits of healthy young adults: use of a sleep questionnaire. Brit J Prev Soc Med 25: 236-41. 1971 Johns MW, Hepburn M, Goodyear MD: Use of hypnotic drugs by hospital patients. Med J Aust 2: 1323-7. 1973 Goodyear MD: Stress, adrenocortical activity and sleep habits. Ergonomics 16: 679-81. (Reprinted in: Shelford AT, ed. Man under Stress. London: Taylor and Francis, 1979: 113-5) 1981 Asano S, Goodyear MD, Burns G, Bartlett P, MacKay IR: Colony formation by T-lymphocytes infiltrating human tumours. Immunology Letters 3: 17-19. Goodyear MD, Mackay IR, Russell IS: Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for Stage II breast cancer. Cancer Chemotherapy Pharmacology 7: 37-40. 1983 Mackay IR, Goodyear MD, Riglar C, Penschow J: Effect on natural and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancer. Cancer Immunol Immunother 16: 98-100. Dr Michael Goodyear: Bibliography
  2. 2. 1984 Mackay IR, Goodyear MD, Riglar C, Penschow J, Whittingham S, Russell IS, Kitchen PR, Collins JP: Effect on immunological and other indices of adjuvant melphalan chemotherapy in breast cancer. Cancer 53: 2619-2627 1988 Levine MN, Gent M, Hirsh J, Arnold A, Goodyear M, Hryniuk W, DePauw S: The thrombogenic effect of anti-cancer therapy in women with stage II breast cancer, N Eng J Med 318: 404-7. Browman GP, Levine MN, Goodyear M, Russell R, Archibald SD, Jackson BS, Young JEM, Basrur V, Johanson C: Methotrexate/ 5-Fluorouracil scheduling influences normal tissue toxicity but not anti-tumour effect in patients with squamous cell head and neck cancer. J Clin Oncol 6: 963-68. Levine MN, Guyatt GG, Gent M, DePauw S, Goodyear M, Hryniuk W, Arnold A, Findlay B, Skillings JR, Bramwell VH, Levin L, Bush H, Abu-Zahra H, Kotalik J: Quality of life in stage II breast cancer. An instrument for clinical trials. J Clin Oncol 6: 1798-1810. 1989 Levine MN, Planes A, Hirsh J, Goodyear M, Vochelle N, Gent M: The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement. Thromb Haemostas 62:940-944. 1990 Figueredo A, Arnold A, Goodyear M, Findlay B, Neville A, Normandeau R, Jones A: Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase I/II study. Cancer 65: 1895-1902. Browman GP, Goodyear MDE, Levine MN, Russell R, Archibald SD, Young, JEM: Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer. A randomized placebo- controlled clinical trial. J Clin Oncol 8: 203-208. Levine MN, Gent M, Hryniuk WM, Bramwell V, Abu-Zahra H, DePauw S, Arnold A, Findlay B, Levin L, Skillings J, Bush H, Goodyear MD, Roberts R: A randomised trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer. J Clin Oncol 8: 1217-1225. 1991 Meyer RM, Hryniuk WM, Goodyear MDE: The role of dose intensity in determining outcome in intermediate grade non-Hodgkin's lymphoma. J Clin Oncol 9: 339-347. Levine MN, Browman GP, Gent M, Roberts R, Goodyear M: When is a prognostic factor useful?: a guide for the perplexed. J Clin Oncol 9: 348-356. http://myweb.dal.ca/mgoodyea/files/whenisaprognosticfactoruseful.pdf 1992 Levine MN, Bramwell V, Abu-Zahra H, Goodyear MD, Arnold A, Findlay B: The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation. Brit J Cancer 65: 130-132. 1993 Jones GW, Browman G, Goodyear M, Marcellus D, Hodson DI: Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer. Head and Neck 15: 497-503. 1994 Goodyear MDE: Death or taxes? An examination of recent changes in tobacco taxation policy in Canada. Can Resp J 1: 95-103. 1995 de Gara CJ, Basrur V, Figueredo A, Goodyear M, Knight P: The influence of age on the management of anal cancer. Hepato-Gastroenterology 42: 73-76. Carey MS, O'Connell GJ, Johanson CR, Goodyear MD, Murphy J, Daya DM, Schepansky A, Peloquin A, Lumsden B: Good outcome associated with a standardised treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecologic Oncology 57: 138- 144. Dr Michael Goodyear: Bibliography
  3. 3. 1996 Forsyth P, Cairncross G, Stewart D, Goodyear M, Wainman N, Eisenhauer E: Phase II trial of docetaxel in patients with recurrent malignant glioma. Investigational New Drugs 14(2): 203-206. http://myweb.dal.ca/mgoodyea/files/phaseIIdocetaxelglioma.pdf 1997 Reiter HI, de Gara C, Figueredo A, Goodyear M, Whelan T: Evidence for CEA utilization following curative resection of colorectal cancer. GI Cancer 2: 153-158. 2000 Gertler SZ, MacDonald D, Goodyear M, Forsythe P, Stewart DJ, Belanger K, Perry J, Fulton D, Steward W, Wainman N, Seymour L,: NCIC CTG phase II study of gemcitabine in patients with malignant glioma (IND.94). Ann Oncol 11(3): 315-318. http://annonc.oxfordjournals.org/cgi/reprint/11/3/315 2001 Willett C, Ajani J, Kelsen D, Sigurdson E, Abrams R, Berkey B, Benetz M, Crane C, Gaspar L, Goodyear MD, Gunderson L, Haddock M, Hoffmann J, Janjan N, John M, Kachnic L, Krieg R, Landry J, Meropol N, Minsky B, Mitchell E, Mohiuddin M, Moulder J, Myerson R, Noyes D, Pajak TF, Raben D, Regine W, Rich T, Robertson JM, Russell A, Skibber J, Kim P. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee. Int J Radiat Oncol Biol Phys. 2001;51(3 Suppl 2):19-27. http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T7X-4465J4M-5- 3&_cdi=5070&_user=2493797&_orig=browse&_coverDate=12%2F31%2F2001&_sk=999489996.8997&view =c&wchp=dGLbVzz-zSkWW&md5=ef858beb0c704d66567ba392e433a765&ie=/sdarticle.pdf 2005 Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson DR. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter- associated thrombosis in patients with cancer. J Clin Oncol. Jun 20;23(18):4063-9. http://www.jco.org/cgi/reprint/23/18/4063 ABSTRACTS (Journal): 1972 Johns MW, Goodyear MD, Masterton JP: Changes with age in the duration of sleep in human adults. Psychophysiology 9: 97 (First International Association for the Psychophysiological Study of Sleep, Bruges, Belgium, June 1971). Johns MW, Gay TJ, Goodyear MD, Bruce DW: Relationship of levels of adrenocortical activity and personality habits. Psychophysiology 9: 102. Ibid. 1975 Fox RM, Crockett B, Goodyear MD, Garson OM: Bone marrow transplantation in acute leukaemia. Aust NZ J Med 5: 287-88 (Annual Meeting of the Royal Australasian College of Physicians, 1975). 1982 Goodyear MD, Ege GN, Sutherland DJ, Meakin JW, Myers RE: Prognostic value of postoperative internal mammary lymphoscintigraphy in prediction of recurrence and survival in primary breast cancer. Breast Cancer Research and Treatment 2: 64 (Fifth Annual Breast Cancer Symposium, San Antonio, Texas, November 1982). 1985 Goodyear M, Hryniuk W, Figueredo A, Levine M, McCulloch P, Clark D, Kotalik J: Dose-intensity as a predictor of response and survival in the treatment of advanced breast carcinoma with chemotherapy. Clin Invest Med 8: A163 (Fifty-Fourth Annual Meeting of the Royal College of Physicians and Surgeons of Canada, Vancouver, British Columbia, September 1985). 1987 Hryniuk W, Plenderleith I, Goodyear M, Levine M: A prospective trial of dose intensity in chemotherapy of advanced breast cancer. Clin Invest Med 10: B111 (Fifty-Sixth Annual Meeting of the Royal College of Physicians and Surgeons of Canada, Winnipeg, Manitoba, September 1987). 1989 Levine M, Bertomeu MC, Lauri D, Goodyear M, Buchanan MR: Chemotherapy and thrombosis: chemotherapy enhances platelet adhesion to the endothelium. Breast Cancer Research and Treatment 14: 147 (Twelfth Annual Breast Cancer Symposium, San Antonio, Texas, December 1989). Dr Michael Goodyear: Bibliography
  4. 4. Ward J, Neame PB, Goodyear M, Soamboonsrup P, Browman GP: The prognostic implication of immunophenotyping in acute nonlymphocytic leukemia. Blood 74S: 238a (Thirty-First Annual Meeting of the American Society of Hematology, Atlanta, Georgia, December 1989). 1990 Levine M, Goodyear M, Gent M, Hryniuk W, Bramwell V, Abu-Zahra H: Systemic adjuvant chemotherapy reduces ipsilateral breast recurrence following lumpectomy: results from a randomised trial. Breast Cancer Research and Treatment 16: 172 (Thirteenth Annual Breast Cancer Symposium, San Antonio, Texas, November 1990). Levine MN, Browman GP, Gent M, Roberts R, Goodyear M: When is a prognostic factor useful?: a guide for the perplexed. Breast Cancer Research and Treatment 16: 185. (Thirteenth Annual Breast Cancer Symposium, San Antonio, Texas, November 1990). 1994 de Gara CJ, Morgan DG, Miller JD, Goodyear MD, McCarty D, Basrur V, Figueredo A, Young JEM: Multimodality treatment of esophageal cancer. Can J Surg 37: 346. (Sixty-Third Annual Meeting of the Royal College of Physicians and Surgeons of Canada, Toronto, Ontario, September 1994). 1996 Rojas F, Whitton A, Goodyear M, Rathbone M, Hodson I, Macdonald D, Sathya J: Prognosis and management of oligodendrogliomas. IJROBP 36: S289 (#2022) (Thirty-Eighth Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Los Angeles, California, October 1996). 2009 Kachnic L, Winter K, Myerson R, Goodyear M, Willins J, Esthappan J, Haddock M, Rotman M, Parikh P, Willett C: RTOG 0529: A Phase II Evaluation of Dose-painted IMRT in Combination with 5-Fluorouracil and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal. IJROBP 75: S5 (#10) (Fifty-First Annual Meeting of the American Society for Radiation Oncology, Chicago, Illinois, November 2009) ABSTRACTS (Proceedings of Meetings): 1972 Goodyear MD, Stress, adrenocortical activity and sleep habits. (Proceedings of the Ninth Annual Meeting, Ergonomics Society of Australia and New Zealand, Adelaide, South Australia). 1979 Goodyear MD, Mackay IR, Russell IS: Effect of adjuvant cytotoxic chemotherapy on immunological indices in Stage II breast cancer. (Proceedings of the Sixth Annual Scientific Meeting of the Clinical Oncological Society of Australia; Melbourne, Victoria, November : 55). Asano S, Riglar C, Goodyear MD, Mackay IR: Human melanoma cell growth in agar. (Proceedings of the Sixth Annual Scientific Meeting of the Clinical Oncological Society of Australia; Melbourne, Victoria, November : 98). Nesbitt RA, Tattersall MH, Woods RL, Fox RM, Forbes J, Mackay IR, Goodyear MD: Tamoxifen therapy of advanced malignant melanoma. (Proceedings of the Sixth Annual Scientific Meeting of the Clinical Oncological Society of Australia; Melbourne, Victoria, November : 165). 1981 Mackay IR, Riglar C, Kitchen PR, Collins JP, Goodyear MD: Delayed effects of adjuvant cytotoxic chemotherapy on the lymphoid system and bone marrow in Stage II breast cancer. (Proceedings of the Eighth Annual Scientific Meeting of the Clinical Oncological Society of Australia; Melbourne, Victoria, November : 9). Goodyear MD, MacKay IR, Russell IS, Riglar C: Prolonged toxicity from adjuvant chemotherapy in breast cancer. (Proceedings of the Third International Conference on the adjuvant therapy of cancer; Tucson, Arizona, March : 15). Dr Michael Goodyear: Bibliography
  5. 5. 1982 Goodyear MD, Malkin A, Sutherland DJ, Caplan B, Malkin DG, Kellen JA: The association of creatine kinase BB isozyme with estrogen and progesterone, receptor content in human breast cancer cytosol. (Proceedings of the Seventy-Third Annual Meeting of the American Association for Cancer Research; St. Louis, Missouri, April : 23: 9). Goodyear MD, Malkin A, Sutherland DJ, Caplan B, Malkin DG, Kellen JA: Association between steroidal receptor levels and creatinine kinase isozyme BB in human breast cancer cytosol. (Proceedings of the Thirteenth International Cancer Congress; Seattle, Washington, September : 588). Mackay IR, Goodyear MD, Russell IS, Riglar C, Kitchen PR, Collins JP: Delayed effects of adjuvant cytotoxic chemotherapy on the lymphoid system and bone marrow in stage II breast cancer. (Proceedings of the Thirteenth International Cancer Congress; Seattle, Washington, September : 593). Goodyear MD, Prognostic value of postoperative levels of carcinoembryonic antigen (CEA) for recurrence and survival in primary breast cancer. (Fundamental Problems in Breast Cancer, Jasper, Alberta, September). Malkin A, Goodyear MD, Perspectives on the Clinical Use of Tumour Markers in Breast Cancer. (Coauthor A. Malkin). Twenty-Sixth Annual Clinical Conference (Current Controversies in Breast Cancer, M.D. Anderson Hospital and Tumour Institute, Houston, Texas, November). 1983 Malkin A, Goodyear MD, Wong A, Caplan B, Malkin DG, Sutherland DJ: CEA and enzymes of carbohydrate metabolism in predicting estrogen and progesterone receptor status in human breast cancer cytosols. (Third EORTC Breast Cancer Working Conference; Amsterdam, April). Goodyear MD, Malkin A, Sutherland D, Caplan B, Malkin DG: Predictive ability of enzyme profiles for estrogen and progesterone receptors in human breast cancer cytosols. (Proceedings of the Seventy-Fourth Annual Meeting of the American Association for Cancer Research; San Diego, California, April : 23: 723). Goodyear MD, Malkin A, Malkin DG, Sutherland DJ: Relationship between estrogen and progesterone receptors and carcino-embryonic antigen in human breast cancer cytosols. (Proceedings of the Nineteenth Annual Meeting of the American Society of Clinical Oncology; San Diego, California, April : 2: 15). Goodyear MD, Malkin A, Relationship between estrogen and progesterone receptors and carcinoembryonic antigen, in human breast cancer cytosols. Thirty-Sixth Annual Symposium on Fundamental Cancer Research (Cancer Invasion and Metastases: Biological and Therapeutic, M.D. Anderson Hospital and Tumor Institute, Houston, Texas, November). 1984 Goodyear MD, Mackay I, Collins J, Russell I, Kotalik J, Hryniuk W, Levine M, McCulloch P: Comparison of haematologic recovery following varying adjuvant chemotherapy regimes. (Proceedings of the Twentieth Annual Meeting of the American Society of Clinical Oncology; Toronto, Canada, May: 3: 118). 1985 Goodyear M, Hryniuk W, Clark D, Figueredo A, Levine M, McCulloch P: Relationship of dose intensity to outcome of advanced breast carcinoma. (Proceedings of the Twenty-First Annual Meeting of the American Society of Clinical Oncology; Houston, Texas. May : 4: 61. Hryniuk W, Goodyear M, Clark D, Figueredo A, Levine M, McCulloch P: Dose Intensity predicts for eventual response to chemotherapy of advanced breast carcinoma. (Proceedings of the Third European Conference on Clinical Oncology; Stockholm, Sweden, June : 12). Goodyear M, Hryniuk W, Figueredo A, Levine M, McCulloch P, Clark D, Kotalik J, Bush H: Retrospective review of dose intensity in relation to response to chemotherapy in advanced breast cancer. Dr Michael Goodyear: Bibliography
  6. 6. (Proceedings of the Tenth Clinical Cancer Research Conference, Ontario Cancer Treatment and Research Foundation; Lake Couchiching, Ontario, September : 10). 1987 Browman G, Levine M, Russell R, Goodyear M, Archibald S, Jackson S, Young JEM: Randomized Trial of Simultaneous versus 18 Hours Sequential Methotrexate 5-Fluorouracil in Head and Neck Cancer. (Proceedings of the Twenty-Third Annual Meeting of the American Society of Clinical Oncology; Atlanta, Georgia, May : 6: 123). 1988 Goodyear M: Do doxorubicin and its enantiomer, 4'-epi-doxorubicin have equivalent activity? A meta-analysis of randomised trials comparing two analogues. (Proceedings of the Seventy-Ninth Annual Meeting of the American Association for Cancer Research; New Orleans, Louisiana, May : 29: 192). Browman GP, Levine M, Hodson I, Russell R, McAlpine L, Goodyear M, Sathya J, Rider W: A new quality of life index for head and neck cancer patients receiving radical radiotherapy. (Proceedings of the Twenty-Fourth Annual Meeting of the American Society of Clinical Oncology; New Orleans, Louisiana, May : 7: 154). Figueredo A, Arnold A, Findlay B, Goodyear M, Neville A, Normandeau R, Jones A: Pilot study of verapamil and tamoxifen added to chemotherapy of extensive small cell lung cancer. (Proceedings of the Twenty-Fourth Annual Meeting of the American Society of Clinical Oncology; New Orleans, Louisiana, May : 7: 208). O'Connell GJ, Morgan HR, Ingram D, Roth P, Murphy KJ, Daya D, D'Souza T, Goodyear M: A randomised controlled trial comparing cryotherapy and laser therapy in the treatment of cervical intraepithelial neoplasia. (Proceedings of the Society of Obstetricians and Gynaecologists of Canada; Vancouver, BC, June). 1989 Goodyear M, Browman GP, Russell R, Plant S, McBride J: Serum and RBC Folates in patients with advanced Head and Neck Cancer receiving chemotherapy with MTX+/- 5FU and leucovorin. (Proceedings of the Eightieth Annual Meeting of the American Association of Cancer Research; San Francisco, California, May 30: 276). Browman GP, Goodyear M, Russell R, Archibald S, Young JEM: Abrogation of both toxicity and antitumor effects of standard dose methotrexate by low dose leucovorin: Results of a double blind placebo controlled randomised trial. (Proceedings of the Eightieth Annual Meeting of the American Association of Cancer Research; San Francisco, California, May : 30: 275). Bertomeu MC, Levine M, Lauri D, Goodyear M, Buchanan MR: Chemotherapy and thrombosis: chemotherapy enhances platelet adhesion to the endothelium. (Proceedings of the Eightieth Annual Meeting of the American Association of Cancer Research; San Francisco, California, May : 30: 284). Meyer RM, Goodyear M, Bryant D, Browman GP: Potential impact of increased vincristine dose in adult acute lymphoblastic leukemia. (Proceedings of the Twenty-Fifth Annual Meeting of the American Society of Clinical Oncology; San Francisco, California, May : 8: 798). Browman GP, Goodyear MD, Levine MN, Hodson I, Russell R, McAlpine L, Sathya J, Cripps C, Eapen L, Skingley P: Evaluation of a quality of life/toxicity index for patients receiving radiation +/- chemotherapy for head and neck cancer. (Proceedings of the Twenty-Fifth Annual Meeting of the American Society of Clinical Oncology; San Francisco, California, May : 8: 1220). O'Connell GJ, Carey M, Johanson C, Murphy KJ, Daya D, Goodyear M: Endometrial carcinoma - Is abdominal hysterectomy and bilateral salpingo-oophorectomy enough surgery? (Proceedings of the Second Annual Meeting of the International Gynecologic Cancer Society; Toronto, Ontario, October). Dr Michael Goodyear: Bibliography
  7. 7. O'Connell GJ, Daya D, Caussey H, Rawls W, Goodyear M: A critical analysis of prognostic factors in the treatment of CIN in a randomised controlled trial. (Proceedings of the Society of Obstetricians and Gynaecologists of Canada; Québec, PQ, June), (Proceedings of the Second Annual Meeting of the International Gynecologic Cancer Society; Toronto, Ontario, October), (Proceedings of the Canadian Association of Pathologists; Ottawa, Ontario). 1990 Levine M, Goodyear M, Gent M, Hryniuk W, Bramwell V, Abu-Zahra H: Systemic adjuvant chemotherapy reduces ipsilateral breast recurrence following lumpectomy. Results from a randomised trial. (Proceedings of the Twenty-Sixth Annual Meeting of the American Society of Clinical Oncology; Washington, DC, May : 9: 33). Poulin J, O'Connell GJ, Daya D, Goodyear M: Serous surface papillary carcinoma. Survival comparison with serous ovarian papillary carcinoma. (Proceedings of the Society of Obstetricians and Gynaecologists of Canada; Halifax, NS, June). Marcellus D, Browman G, Goodyear M, Schneider K, Hodson I, Levine M: Methotrexate-based neoadjuvant chemotherapy as a predictor of radiation response in advanced squamous cell head and neck cancer. (Proceedings of the Fourteenth Annual Meeting of the Western Great Lakes Head and Neck Oncology Association; Hamilton, Ontario, November). 1991 Daya D, O'Connell G, Goodyear M: Histologic grading of advanced serous ovarian carcinoma has no prognostic significance in patients treated with cis-platinum. (Proceedings of the Thirteenth World Congress of Gynaecology and Obstetrics; Singapore, September). Goodyear M: An estimate of attributable mortality in the Ontario workforce due to environmental tobacco smoke. (Proceedings of the Eighty-Second Annual Meeting of the American Association for Cancer Research; Houston, Texas, May : 32: 221). Marcellus D, Browman G, Goodyear M, Schneider K, Russell R, Hodson I, Levine M, Archibald S, Young J: Prediction of radiation response in patients receiving methotrexate-based neoadjuvant chemotherapy for locally advanced head and neck cancer. (Proceedings of the Twenty-Seventh Annual Meeting of the American Society of Clinical Oncology; Houston, Texas, May : 10: 204). 1992 Watson S, O'Connell G, Goodyear M: Pap smear compliance of patients discharged from colposcopy clinic. (Proceedings of the Society of Obstetricians and Gynaecologists of Canada; Vancouver, BC, June). O'Connell G, Goodyear M: A prospective trial of compliance in patients attending colposcopy clinic. (Proceedings of the Society of Obstetricians and Gynaecologists of Canada; Vancouver, BC, June). Jones GW, Browman GP, Goodyear M, Levine M, Hodson I: The T and N integer score (TANIS). A new prognostic staging system for squamous cell head and neck cancer. (Proceedings of the Third International Conference on Head and Neck Cancer; San Francisco, California, July). 1993 Goodyear M, Survey of antiemetic usage and control of nausea and vomiting in an outpatient oncology centre. (Annual meeting of the National Cancer Institute of Canada Clinical trials Group, Montréal, Québec, and Third International Symposium on Oncology Pharmacy Practice, Toronto, Ontario, April). 1994 de Gara CJ, Morgan DG, Miller JD, Goodyear MD, McCarty D, Basrur V, Figueredo A, Young JEM: Oesophageal Cancer: Results of multimodality treatment. (Proceedings of Canadian Society of Surgical Oncology; Montréal, PQ). de Gara CJ, Morgan DG, Miller JD, Goodyear MD, McCarty D, Basrur V, Figueredo A, Young JEM: Treatment of oesophageal cancer: a multimodality multidisciplinary approach. (Proceedings of the American College of Gastroenterology; San Francisco, California, September). Dr Michael Goodyear: Bibliography
  8. 8. Leung Y, O'Connell GJ, Goodyear MD: Overall trends in ovarian cancer survival. The Hamilton experience 1970-1989. (Proceedings of the Western Association of Gynecologic Oncologists; Whistler, BC, June). 1996 Forsyth P, Cairncross G, Stewart D, Goodyear M, Fulton D, Wainman N, Eisenhauer E: A phase II trial of docetaxel in patients with recurrent malignant glioma. (Proceedings of the Forty-Eighth Annual Meeting of the American Academy of Neurology; San Francisco, California, March). 1998 Gertler SZ, Macdonald D, Goodyear M, Forsythe P, Stewart DJ, Seymour L, Wainman N: NCIC CTG phase II study of gemcitabine in patients with malignant glioma (IND.94). (Proceedings of the Thirty- Fourth Annual Meeting of the American Society of Clinical Oncology; Los Angeles, California, May : 17). 2002 Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Macleod D, Burton E, Andreou P, Anderson D. A Randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis inpatients with cancer. (Proceedings of the Fourty Fourth Annual Meeting of the American Society of Hematology, Philadelphia, Pennsylvania, December 6 #2769 Blood Nov 16; 100(11)). 2003 Goodyear MDE: Conceptual challenges in the development of practice guidelines for rare tumours: The case of non-pancreatic hepatobiliary cancer. (Proceedings of the Canadian Association of Medical Oncology, Toronto, Ontario, April 24). 2007 Krleza-Jeric K, Dickersin K, Chan AW, Grimshaw J, Goodyear M, Gluud C, Sim I. The Ottawa Statements: Principles and implementation of clinical trial registration and results reporting. (Society for Clinical Trials, Montreal, Quebec May 20) http://myweb.dal.ca/mgoodyea/files/ethics/Ottawa Statements SCT 2007.doc 2010 L. A. Kachnic, K. A. Winter, R. J. Myerson, M. D. Goodyear, J. Willins, J. Esthappan, M. G. Haddock, M. Rotman, P. Parikh, C. G. Willett. RTOG 0529: A phase II study of dose-painted IMRT (DP-IMRT), 5-fluorouracil, and mitomycin-C for the reduction of acute morbidity in anal cancer. ASCO Gastrointestinal Symposium 2011 L. A. Kachnic, K. A. Winter, R. J. Myerson, M. D. E. Goodyear, J. Willins, J. Esthappan, M. G. Haddock, M. Rotman, P. J. Parikh, C. G. Willett. Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-c for the reduction of acute morbidity in carcinoma of the anal canal. ASCO Gastrointestinal Symposium NON PEER REVIEW PUBLICATIONS: BOOK CHAPTERS: 1979 Goodyear M D: Stress, Adrenocortical Activity and Sleep Habits. In Shelford AT (Ed.), Man Under Stress, Taylor and Francis, London. pp 113-115. (Original work). 1989 Goodyear M, Soamboonsrup P, Browman G, Neame PB: The contribution of cytochemistry and immunophenotyping to the classification of acute leukaemia. In Scott CS (Ed.), Leukaemia Cytochemistry, Ellis Horwood, Chichester. pp 201-258. (Original work). 1990 Levine MN, Gent M, Hryniuk WM, Bramwell V, Abu-Zahra H, DePauw S, Arnold A, Findlay B, Skillings J, Bush H, Kotalik J, Goodyear M, Roberts R: A randomised trial comparing 12 weeks Dr Michael Goodyear: Bibliography
  9. 9. with 36 weeks of adjuvant chemotherapy in stage II breast cancer. In Salmon SE (Ed.), Adjuvant therapy of Cancer VI, Saunders, Philadelphia. pp 226-231. (Original work). 1994 Goodyear M: Estimated tobacco attributable mortality for selected regions, Ontario and Canada. In Dickson LL, Heale JAD, Chambers LW (Eds.), Fact Book on Health in Hamilton-Wentworth, Health Priorities Analysis Unit, Faculty of Health Sciences, McMaster University, Hamilton, Ontario. p 87. (Original work). 1995 Goodyear MDE, Fraumeni MA: Incorporating quality of life assessment into clinical cancer trials. In Spilker B (Ed.), Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd Edition, Lippincott-Raven, Philadelphia. pp 1003-1013. (Survey of field). 2007 Goodyear M. Disciplinary procedures in health care: Use and abuse. In Savage W (Ed.), Birth and Power - A Savage Enquiry Revisited. Middlesex University Press, London. (Review and analysis of literature) http://www.mupress.co.uk/products.asp?partno=978%201%20904750%2058%201 http://myweb.dal.ca/mgoodyea/files/disciplinaryproceduresinhealthcare.doc 2011 Goodyear M, Weitzer R. International trends in the control of sexual services, in Dewey S, Kelly P (eds.), Desire and Labor in Economic Crisis, New York University Press (in press) ORIGINAL ARTICLES: 1984 Goodyear MD, Sutherland DJ, Kellan JA, Malkin A, Malkin DG, Meakin JW, Myers RE: Prognostic value of postoperative levels of carcinoembryonic antigen for recurrence and survival in primary breast cancer. Reviews on Endocrine Related Cancer. Supplement 14: 149-153. 1987 Hryniuk WM, Figueredo A, Goodyear M: Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. Sem Oncol 14 (Sup 4): 3-11. 1990 Taylor M, Walker J, Esdaile D, Goodyear M, Moreau S: The campaign to promote tobacco-free pharmacies. Nova Scotia Med J 156-157. 1992 Goodyear M: Smoking and lung cancer. Ann Roy Col Phys Surg Can 25: 232-233. 1995 Goodyear M: The 1994 tobacco tax reduction. Measuring the effect and counting the cost. Tobacco Research News 1(3): 4-5. EDITORIALS: 1990 Hryniuk WM, Goodyear M: The calculation of received dose intensity. J Clin Oncol 8: 1935-7. http://myweb.dal.ca/mgoodyea/files/calculationofreceiveddoseintensity.pdf 2006 Goodyear M: Learning from the TGN14112 trial. Brit Med J March 25 332(7543): 677-8 http://www.bmj.com/cgi/content/full/332/7543/677 Goodyear MD: Further lessons from the TGN14112 tragedy. Brit Med J August 5 333(7562): 270-1 http://bmj.bmjjournals.com/cgi/content/full/333/7562/270? ijkey=whP3FyWKdYWdMvy&keytype=ref Goodyear MD: A model clinical trials agreement. Brit Med J November 25 333(7578):1083-4. http://www.bmj.com/cgi/rapidpdf/bmj.39030.418229.BEv1 Dr Michael Goodyear: Bibliography
  10. 10. 2007 Goodyear MD, Cusick L: Protection of sex workers. Brit Med J January 13 334(7584):52-3. http://www.bmj.com/cgi/content/full/334/7584/52?ijkey=mjkq1iVzYd7AKfi&keytype=ref Goodyear MD, Krleza-Jeric K, Lemmens T: The Declaration of Helsinki. BMJ. 2007 Sep 29;335(7621):624-5 2008 Goodyear M: Incarceration of female sex workers in China and STI/HIV. Programmes that are not rights-based are doomed to fail. Sex Transm Infect. 2008 Feb;84(1):1-2. http://sti.bmj.com/cgi/content/extract/84/1/1 Goodyear MD, Eckenwiler LA, Ells C: Fresh thinking about the Declaration of Helsinki. Brit Med J. 2008 Oct 17;337:a2128 http://www.bmj.com/cgi/content/full/337/oct17_2/a2128? view=long&pmid=18930967 2009 Goodyear MD, Lemmens T, Sprumont D, Tangwa G. Does the FDA have the authority to trump the Declaration of Helsinki? BMJ. 2009 Apr 21 LETTERS: 1974 Goodyear MD, Forster DC: Hyposplenism in ulcerative colitis. Lancet 2: 658. (Case report). 1977 Goodyear MD: Complications of catheterisation of the external carotid artery. Med J Aust 1: 675. (Case report). 1978 Goodyear MD: Menstruation and heart disease. Am Heart J 95: 675. (Commentary). 1979 Nesbit RA, Woods RL, Tattersall MH, Fox RM, Forbes JF, Mackay IR, Goodyear MD: Tamoxifen in malignant melanoma. N Engl J Med 301: 1241.(Phase II clinical trial). Hryniuk W, Bush H, Levine M, Goodyear M: Dose, Response, and Survival in Metastatic Mammary Cancer. J Clin Oncol 3: 890-891. (Response) 1985 Hryniuk WH, Bush H, Levine M, Goodyear MD: Dose, response and survival in metastatic mammary cancer. J Clin Oncol 3: 890-891.(Commentary). 1986 Goodyear MD: Adjuvant chemotherapy. J Clin Oncol 4: 259-260.(Commentary). Goodyear MD: The problem of mixed cellularity lymphoma. J Clin Oncol 4: 263-264. (Commentary). Goodyear MD: Comparison of CAF versus CMFP in metastatic breast cancer. J Clin Oncol 4: 442-443.(Commentary). Goodyear MD: Chemotherapy in metastatic lung cancer. J Clin Oncol 4: 1150-1151.(Commentary). 1988 Goodyear MD: Tobacco advertising in the waiting room. Can Med Assoc J 138: 682-683. 1989 Goodyear MD, Levine M: Simplifying infusion chemotherapy. J Roy Soc Med 82: 184. (Commentary). Dr Michael Goodyear: Bibliography
  11. 11. 1991 Hryniuk WM, Goodyear M: Calculating dose intensity. J Clin Oncol 4: 1714. (Response). Meyer R, Goodyear M, Hryniuk W: Dose intensity and lymphoma. J Clin Oncol 9: 1511. (Response). 2005 Goodyear M: Physician regulate thyself! Can Med Assoc J August 30 173(5): 465 http://www.cmaj.ca/cgi/content/full/173/5/465-a Goodyear M, Lowman J, Fischer B, Green M: Prostitutes are people too. Lancet 8 October 366(9493): 1264-5 http://myweb.dal.ca/mgoodyea/files/prostitutesarepeopletoo.pdf 2007 Goodyear M. Free access to medical information: a moral right? Can Med Assoc J. 2 Jan 176(1):69. http://www.cmaj.ca/cgi/content/full/176/1/69 Goodyear MD. Public health policy must be based on sound evidence. BMJ. Apr 28;334(7599):863- 4. http://myweb.dal.ca/mgoodyea/files/Public%20health%20policy%20must%20be%20based%20on %20sound%20evidence%20Goodyear%20BMJ%202007%20334%20863.pdf ELECTRONIC LETTERS: 2003 Goodyear M. The Triumph of Evil - Edmund Burke or wishful thinking BMJ 10 June http://bmj.com/cgi/eletters/325/7374/1232#33187 Goodyear M. Incorrect reference and link BMJ 20 June http://bmj.com/cgi/eletters/326/7403/1341#33510 Goodyear M. The Plural of Anecdote BMJ 20 June http://bmj.com/cgi/eletters/326/7403/1346#33511 Goodyear M. Talking about dying BMJ 25 July http://bmj.com/cgi/eletters/327/7408/221#34916 Goodyear M. Results misquoted BMJ 20 October http://bmj.com/cgi/eletters/327/7420/885#38391 2004 Goodyear M. Academic Freedom BMJ 30 January http://bmj.com/cgi/eletters/328/7434/244-b#48852 Goodyear M. The Blind leading the Blind? BMJ 24 February http://bmj.com/cgi/eletters/328/7437/432#51411 Goodyear M. From Socrates to Tugwell BMJ 12 March http://bmj.com/cgi/eletters/328/7440/597#53063 Goodyear M.“Expert Patient”: What’s in a name? BMJ March 27 http://bmj.com/cgi/eletters/328/7442/723#54743 Goodyear M. DMCs: Time for ICMJE. BMJ September 27 http://bmj.com/cgi/eletters/329/7465/525#75811 2005 Goodyear M. The management of concerns within health care systems CMAJ 29 March http://www.cmaj.ca/cgi/eletters/172/6/717#2231 Dr Michael Goodyear: Bibliography
  12. 12. 2006 Goodyear M. Send not for whom the bell tolls BMJ 7 March http://bmj.com/cgi/eletters/332/7540/0-f#129597 Goodyear M. Clinical Research in India BMJ 26 March http://bmj.com/cgi/eletters/332/7543/683#130615 Goodyear M. Allocating blame BMJ 26 March http://bmj.com/cgi/eletters/332/7543/683#130586 Goodyear M. Transforming the culture of research Lancet 28 March Goodyear M. Editorial responsibility BMJ 12 June http://bmj.com/cgi/eletters/332/7554/0-f#135428 Goodyear M. From Mercky Waters to Greater Transparency BMJ 8 July http://bmj.com/cgi/eletters/333/7558/0-f#137686 Goodyear M. Of Mice and Men and Pandora: Looking Back – Moving Forwards BMJ 11 August http://bmj.com/cgi/eletters/332/7543/677#139512 2007 Goodyear M. Is medical information a moral right? CMAJ 13 September http://www.cmaj.ca/cgi/eletters/175/6/557#4662 Goodyear M. Sex work and social benefit. BMJ 15 January http://www.bmj.com/cgi/eletters/334/7584/52#154225 Goodyear M. Identifying the real moral issues. BMJ 15 January http://www.bmj.com/cgi/eletters/334/7584/52#154300 Goodyear M. Professional ethic of care. BMJ 16 January http://www.bmj.com/cgi/eletters/334/7584/52#154241 Goodyear M. Keeping up with the times - New BMJ. BMJ 19 January http://www.bmj.com/cgi/eletters/334/7585/0#154716 Goodyear M. Public health policy must be based on sound evidence, not opinion. BMJ 5 April http://www.bmj.com/cgi/eletters/334/7586/187#163537 Goodyear M. Demythologising and destigmatising sex work. BMJ 14 April http://www.bmj.com/cgi/eletters/334/7597/767#163852 Goodyear M, Krleza-Jeric K, Lemmens T. The declaration of Helsinki and the Ottawa Statement on trial registration BMJ December 18 http://www.bmj.com/cgi/eletters/335/7621/624#184133 2008 Goodyear M, Eckenwiler LA, Ells, C. Update on the Declaration of Helsinki. BMJ October 20 http://www.bmj.com/cgi/eletters/337/oct17_2/a2128#203375 2010 Goodyear M. De facto if not De Jure. CMAJ Sept 20 2010 Dr Michael Goodyear: Bibliography
  13. 13. NON PEER REVIEW PUBLICATIONS (Monographs) MONOGRAPHS, DISCUSSION AND POLICY PAPERS: 1974 Goodyear MD: The Intelligent RMO's Guide to use of the Haematology Service. Prince Henry's Hospital, Melbourne, Australia. Goodyear MD: Anticoagulant Therapy. Prince Henry's Hospital. 1977 Goodyear MD: Control of Pain in Cancer. Prince Henry's Hospital. 1981 Sullivan J, Bell R, Goodyear MD: Cancer Chemotherapeutic Agents. Royal Melbourne Hospital, Melbourne. 2003 Goodyear M. Institutional Jurisdiction. Research Ethics Board July 2003 Goodyear M. Governance, Accountability and Conflict of Interest. Research Ethics Board August 2003 http://myweb.dal.ca/mgoodyea/files/POLICY%20DOCUMENT%20(Governance%20and %20Accountability)%20Review%202.11.doc 2004 Goodyear M. The Management of Concerns within Health Care Systems in the Context of Total Quality Management (rev. 2006) http://myweb.dal.ca/mgoodyea/files/concernsinhealthcare.doc Goodyear M. Effective Team Functioning in Health Care: A keystone of patient safety (rev. 2006) http://myweb.dal.ca/mgoodyea/files/teamfunction.doc Goodyear M, Golec L, Watts SC. Commentary on WHO International Clinical Trials Registry Platform. World Health Organization November 11 2005. http://www.who.int/ictrp/MichaelGoodyear_11Nov2005.pdf 2005 Goodyear M. Assessing the Quality and Appropriateness of Care. http://myweb.dal.ca/mgoodyea/files/Assessingthequalityandappropriatenessofcarev2.doc Goodyear M. Clinical Judgement: Medical Decision Making in Oncology http://myweb.dal.ca/mgoodyea/files/clinicaljudgement.doc 2006 Goodyear M, Golec L. Comments on Disclosure Timing Submission to WHO International Clinical Trials Registry Platform. World Health Organization January 25 http://www.who.int/ictrp/3009_Michael_Goodyear_Lisa_Golec_25Jan06.pdf Goodyear M. Closing the Gaps: Moving Closer to a Collaborative Culture. Comments on Disclosure Timing: Balancing increased transparency and competitive advantage. Submission to WHO International Clinical Trials Registry Platform March 31 2006 http://www.who.int/ictrp/007- Michael_Goodyear_31March06.pdf Goodyear M. Conflict Management in Health Care Teams: A new paradigm - Safer care: Saving costs. http://myweb.dal.ca/mgoodyea/files/conflict.doc Ackroyd S, Allen A, Campbell LA, Goodyear M, Kephart G, Rathwell T, Warner G. (Health Services Research Task Group, Dalhousie University). Developing linkages between health researchers and decision-makers: The rationale for an Institute for the Study of Health Outcomes, 13
  14. 14. NON PEER REVIEW PUBLICATIONS (Monographs) Services and Policy in Nova Scotia. July 2006 2007 Goodyear M. Remembering Ipswich: The case for decriminalisation of prostitution. January http://myweb.dal.ca/mgoodyea/files/rememberingipswich.doc 2009 Goodyear M. Controlling Loose Women: International trends in the regulation of the exchange of sexual services http://myweb.dal.ca/mgoodyea/Documents/Regulation%20and%20control/Controlling%20Loose %20Women.doc ESSAYS 2007 Goodyear M. Decriminalisation of prostitution is a public health and human rights issue. Washington Post on-line March 29 2007. http://newsweek.washingtonpost.com/postglobal/needtoknow/2007/02/debating_legalized_prostitutio .html PUBLICATIONS ON GENERAL TOPICS: 1969-72 Editor's editorials for Panacea (Australian Medical Student’s Journal). 197l Goodyear MD: A time to live, a time to die. Intermedica 1: 10-15. (Editorial). 1972 Goodyear MD: Australian Letter: Medicine in the market. Brit J Hosp Med 8: 101. 1993 Goodyear M: Second-hand smoke is commonest cause of death in non-smokers. Mind and Matter, Science and Technology, Globe and Mail, Toronto December 11th. BOOK REVIEWS: 1996 Peto R, Lopez A et al. (eds.) Mortality from Smoking in Developed Countries 1950-2000. OUP 1994. Can Resp J 3(1) 68. COMMITTEE PRESENTATIONS: 1994 Standing Committee on Health, House of Commons, Ottawa. Towards zero consumption: Generic packaging of tobacco products. May 5 MISCELLANEOUS: Collaborative editing projects with Wikipedia on miscellaneous topics, notably feminism and related issues, including writing the first article on the history of feminism. THESES: The psychoendocrinology of sleep disturbance : Studies in the use of questionnaires to elicit subjective accounts of sleeping patterns, and their interrelations with adrenocortical function, personality profiles and symptomatology. Bachelor of Medical Science (Honours), Department of Surgery, Monash University, Melbourne, Australia, 197l. SOFTWARE: Dose Intensity and Predicted Response Rates - A case simulation. MS-DOS for IBM PCS and compatibles. Distributed internationally by Adria Laboratories, 1987. 14

×